In this paper, we introduce the use of a personalized Gaussian Process model (pGP) to predict per-patient changes in ADAS-Cog13 -- a significant predictor of Alzheimer's Disease (AD) in the cognitive domain -- using data from each patient's previous visits, and testing on future (held-out) data. We start by learning a population-level model using multi-modal data from previously seen patients using a base Gaussian Process (GP) regression. The personalized GP (pGP) is formed by adapting the base GP sequentially over time to a new (target) patient using domain adaptive GPs. We extend this personalized approach to predict the values of ADAS-Cog13 over the future 6, 12, 18, and 24 months. We compare this approach to a GP model trained only on past data of the target patients (tGP), as well as to a new approach that combines pGP with tGP. We find that the new approach, combining pGP with tGP, leads to large improvements in accurately forecasting future ADAS-Cog13 scores.
However, most of these works attempted forecasting of changes in subjects' CS, which deals with a limited number of future outcomes (i.e., either binary or a three-class). By contrast, we aim to forecast ADAS-Cog13, defined on a more fine-grained scale (85 levels), which poses a more challenging machine learning problem. While in our recent work @cite_21 , we investigated forecasting of ADAS-Cog13 along with other scores (CDSRB, CS, and MMSE), we did so for one step ahead (6 months). In this work, we attempt forecasting of up to 24 months ahead by focusing on ADAS-Cog13.
@cite_21
2772764138
In this paper, we introduce the use of a personalized Gaussian Process model (pGP) to predict the key metrics of Alzheimer's Disease progression (MMSE, ADAS-Cog13, CDRSB and CS) based on each patient's previous visits. We start by learning a population-level model using multi-modal data from previously seen patients using the base Gaussian Process (GP) regression. Then, this model is adapted sequentially over time to a new patient using domain adaptive GPs to form the patient's pGP. We show that this new approach, together with an auto-regressive formulation, leads to significant improvements in forecasting future clinical status and cognitive scores for target patients when compared to modeling the population with traditional GPs.